Date | Price Target | Rating | Analyst |
---|---|---|---|
5/30/2024 | $405.00 | Outperform | Robert W. Baird |
3/28/2024 | $439.00 | Neutral → Underperform | BofA Securities |
3/6/2024 | $437.00 | Equal Weight | Barclays |
2/15/2024 | $367.00 → $420.00 | Underweight → Equal Weight | Wells Fargo |
6/20/2023 | $310.00 | Neutral | UBS |
4/21/2023 | $354.00 | Overweight | Cantor Fitzgerald |
12/13/2022 | $388.00 | Underperform → Neutral | BofA Securities |
10/3/2022 | $360.00 | Overweight | JP Morgan |
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that Senior Executive Vice President and Chief Financial Officer, Mark Keim, will assume an expanded role which will now include leadership of the Company's Medicaid Health Plans and Marketplace business. His responsibilities as Chief Financial Officer of the enterprise remain unchanged. Keim, 59, joined Molina in January of 2018 and was named Chief Financial Officer in February 2021. "Mark has been an extraordinary leader not only in the realm of finance, but also in strategic development and operations," said Molina President and CEO Joe Zubretsky. "Formally extending that leadership and results orientation
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that its Board of Directors has entered into a contract amendment with President and Chief Executive Officer, Joe Zubretsky, designed to secure Mr. Zubretsky's tenure through at least the end of 2027. Zubretsky, 67, joined Molina as President and Chief Executive Officer in November of 2017. "Under Joe's leadership we have the right strategy, great execution, and have created significant value for shareholders," said Dale Wolf, Molina's Chairman of the Board. "We are delighted that Joe will be at the helm for the foreseeable future to continue to do so." Under this contract amendment, Zubretsky was awarded a s
Cantor Fitzgerald analyst Sarah James reiterates Molina Healthcare (NYSE:MOH) with a Overweight and maintains $406 price target.
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,446 $ 8,042 $ 18,950
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2024, after the market closes on Wednesday, July 24, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, July 25, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 8508329. A telephonic replay of the conference call will be available through Thursday, August 1, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5266367. A live broadcast of Molina Healthcare's conference call will be available on the Company's website, molinah
Robert W. Baird initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $405.00
BofA Securities downgraded Molina Healthcare from Neutral to Underperform and set a new price target of $439.00
Barclays initiated coverage of Molina Healthcare with a rating of Equal Weight and set a new price target of $437.00
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)